Skip to main content
. 2022 Jun;11(6):1697–1704. doi: 10.21037/tcr-22-1194

Table 4. Neoadjuvant TRAEsa.

Patients (n=8) Grade 1–2 Grade 3 Grade 4
Anemia 7
Neutropenia 3 2 1
Thrombocytopenia 3
Alopecia [grades 1, 2] 7 [3, 4]
Arthralgia 2
Diarrhea 1
Asthenia 6 1
Nausea 4 2
Pruritus 4 1
Rash 4
Peripheral neuritis 2
Hypothyroidism 2
Constipation 2

a, TRAEs that occurred in more than two cases or > grade 2 were recorded here. Grade 1: alopecia <50%; grade 2: alopecia >50%. –, no. TRAEs, treatment-related adverse events.